Detalles de la búsqueda
1.
Nirmatrelvir/Ritonavir Use and Hospitalizations or Death in a Previously Uninfected Nonhospitalized High-Risk Population With COVID-19: A Matched Cohort Study.
J Infect Dis
; 229(1): 147-154, 2024 Jan 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-37711076
2.
Molnupiravir Use and 30-Day Hospitalizations or Death in a Previously Uninfected Nonhospitalized High-risk Population With COVID-19.
J Infect Dis
; 228(8): 1033-1041, 2023 10 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-37260359
3.
Rate and Risk Factors for Severe/Critical Disease Among Fully Vaccinated Persons With Breakthrough Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in a High-Risk National Population.
Clin Infect Dis
; 75(1): e849-e856, 2022 08 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-34893812
4.
Vaccine Effectiveness of 3 Versus 2 Doses of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) mRNA Vaccines in a High-Risk National Population.
Clin Infect Dis
; 75(1): e579-e584, 2022 08 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-35245940
5.
Real-World Effectiveness of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) mRNA Vaccines in Preventing Confirmed Infection in Patients on Chronic Hemodialysis.
Clin Infect Dis
; 75(1): e617-e622, 2022 08 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-35139175
6.
Relative Vaccine Effectiveness of a Severe Acute Respiratory Syndrome Coronavirus 2 Messenger RNA Vaccine Booster Dose Against the Omicron Variant.
Clin Infect Dis
; 75(12): 2161-2168, 2022 12 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-35511586
7.
Precore and Basal Core Promoter Hepatitis B Virus (HBV) Variants Are Present From a Young Age and Differ Across HBV Genotypes.
Hepatology
; 73(5): 1637-1651, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-32860463
8.
SARS-CoV-2 Vaccine Effectiveness in a High-Risk National Population in a Real-World Setting.
Ann Intern Med
; 174(10): 1404-1408, 2021 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-34280332
9.
Mortality is not increased in SARS-CoV-2 infected persons with hepatitis C virus infection.
Liver Int
; 41(8): 1824-1831, 2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-33534931
10.
Hepatitis C Virus (HCV) Treatment With Directly Acting Agents Reduces the Risk of Incident Diabetes: Results From Electronically Retrieved Cohort of HCV Infected Veterans (ERCHIVES).
Clin Infect Dis
; 70(6): 1153-1160, 2020 03 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-30977808
11.
Liver Fibrosis Progression and Mortality in Hepatitis B- and C-Coinfected Persons Treated With Directly Acting Antiviral Agents: Results From ERCHIVES.
Clin Infect Dis
; 71(3): 664-666, 2020 07 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-31840746
12.
Treatment of HCV reduces viral hepatitis-associated liver-related mortality in patients: An ERCHIVES study.
J Hepatol
; 73(2): 277-284, 2020 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32145260
13.
Direct-Acting Antiviral Therapy for HCV Infection Is Associated With a Reduced Risk of Cardiovascular Disease Events.
Gastroenterology
; 156(4): 987-996.e8, 2019 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-30445009
14.
Trends in Treatment Uptake and Provider Specialty for Hepatitis C Virus (HCV) Infection in the Veterans Affairs Healthcare System: Results From the Electronically Retrieved Cohort of HCV-Infected Veterans (ERCHIVES).
Clin Infect Dis
; 68(5): 857-859, 2019 02 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-30137251
15.
Deferred treatment with a fixed-dose combination of sofosbuvir-velpatasvir for chronic hepatitis C virus genotype 1, 2, 4 and 6 infection.
J Viral Hepat
; 26(10): 1229-1232, 2019 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-31216086
16.
The short-term incidence of hepatocellular carcinoma is not increased after hepatitis C treatment with direct-acting antivirals: An ERCHIVES study.
Hepatology
; 67(6): 2244-2253, 2018 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-29205416
17.
Outcomes in Adults With Acute Liver Failure Between 1998 and 2013: An Observational Cohort Study.
Ann Intern Med
; 164(11): 724-32, 2016 Jun 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-27043883
18.
Effect of addition of statins to antiviral therapy in hepatitis C virus-infected persons: Results from ERCHIVES.
Hepatology
; 62(2): 365-74, 2015 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-25847403
19.
Sofosbuvir-based regimens in clinical practice achieve SVR rates closer to clinical trials: results from ERCHIVES.
Liver Int
; 36(5): 651-8, 2016 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-26616353
20.
Treatment adherence and virological response rates in hepatitis C virus infected persons treated with sofosbuvir-based regimens: results from ERCHIVES.
Liver Int
; 36(9): 1275-83, 2016 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-26928927